Validation pour Ingenuity287

vers la météo de la validation par utilisateur

Ingenuity287

precedent - 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 - suivant

Phrase 50 - PMID ?

In periportal region of liver from female SP , oral administration of NODE ( with a treatment period of 24 weeks ) causes little or no change in expression of SP NODE protein(s) .

Non annotée
Je ne sais pas
Je n'ai pas trouvé d'analyse satisfaisante

Commentaires :

Analyse 0

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+                               +---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                                         +COMP:N-N(of+        +----------COMP:V-N(in)---------+           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +------OBJ:V-N------+           |           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:V-N(in) (cause,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 1

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+                               +---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                                         +COMP:N-N(of+        +----------COMP:V-N(in)---------+           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +------OBJ:V-N------+           |           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:V-N(in) (cause,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 2

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+                               +---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                                         +COMP:N-N(of+        +----------COMP:V-N(in)---------+           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +------OBJ:V-N------+           |           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:V-N(in) (cause,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 3

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+                               +---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                                         +COMP:N-N(of+        +----------COMP:V-N(in)---------+           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +------OBJ:V-N------+           |           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:V-N(in) (cause,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 4

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+                               +---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                                         +COMP:N-N(of+        +----------COMP:V-N(in)---------+           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +------OBJ:V-N------+           |           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:V-N(in) (cause,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 5

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+                               +---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                                         +COMP:N-N(of+        +----------COMP:V-N(in)---------+           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +------OBJ:V-N------+           |           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:V-N(in) (cause,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 6

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+                               +---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                                         +COMP:N-N(of+        +----------COMP:V-N(in)---------+           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +------OBJ:V-N------+           |           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:V-N(in) (cause,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 7

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+                               +---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                                         +COMP:N-N(of+        +----------COMP:V-N(in)---------+           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +------OBJ:V-N------+           |           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:V-N(in) (cause,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 8

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+                               +---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                                         +COMP:N-N(of+        +----------COMP:V-N(in)---------+           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +------OBJ:V-N------+           |           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:V-N(in) (cause,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 9

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+                               +---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                                         +COMP:N-N(of+        +----------COMP:V-N(in)---------+           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +------OBJ:V-N------+           |           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:V-N(in) (cause,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 10

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+                               +---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                                         +COMP:N-N(of+        +----------COMP:V-N(in)---------+           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +------OBJ:V-N------+           |           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:V-N(in) (cause,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 11

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+                               +---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                                         +COMP:N-N(of+        +----------COMP:V-N(in)---------+           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +------OBJ:V-N------+           |           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:V-N(in) (cause,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 12

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+                               +---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                                         +COMP:N-N(of+        +----------COMP:V-N(in)---------+           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +------OBJ:V-N------+           |           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:V-N(in) (cause,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 13

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+                               +---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                                         +COMP:N-N(of+        +----------COMP:V-N(in)---------+           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +------OBJ:V-N------+           |           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:V-N(in) (cause,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 14

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+                               +---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                                         +COMP:N-N(of+        +----------COMP:V-N(in)---------+           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +------OBJ:V-N------+           |           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:V-N(in) (cause,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 15

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+----------COMP:V-N(in)---------+---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                                         +COMP:N-N(of+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +OBJ:V-+            |           |           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:V-N(in) (cause,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 16

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+----------COMP:V-N(in)---------+---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                                         +COMP:N-N(of+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +OBJ:V-+            |           |           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:V-N(in) (cause,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 17

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+----------COMP:V-N(in)---------+---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                                         +COMP:N-N(of+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +OBJ:V-+            |           |           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:V-N(in) (cause,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 18

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+----------COMP:V-N(in)---------+---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                                         +COMP:N-N(of+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +OBJ:V-+            |           |           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:V-N(in) (cause,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 19

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+----------COMP:V-N(in)---------+---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                                         +COMP:N-N(of+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +OBJ:V-+            |           |           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:V-N(in) (cause,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 20

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+----------COMP:V-N(in)---------+---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                                         +COMP:N-N(of+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +OBJ:V-+            |           |           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:V-N(in) (cause,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 21

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+----------COMP:V-N(in)---------+---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                                         +COMP:N-N(of+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +OBJ:V-+            |           |           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:V-N(in) (cause,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 22

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+----------COMP:V-N(in)---------+---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                                         +COMP:N-N(of+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +OBJ:V-+            |           |           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:V-N(in) (cause,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 23

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+----------COMP:V-N(in)---------+---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                                         +COMP:N-N(of+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +OBJ:V-+            |           |           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:V-N(in) (cause,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 24

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+----------COMP:V-N(in)---------+---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                                         +COMP:N-N(of+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +OBJ:V-+            |           |           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:V-N(in) (cause,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 25

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+----------COMP:V-N(in)---------+---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                                         +COMP:N-N(of+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +OBJ:V-+            |           |           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:V-N(in) (cause,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 26

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+----------COMP:V-N(in)---------+---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                                         +COMP:N-N(of+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +OBJ:V-+            |           |           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:V-N(in) (cause,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 27

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+                               +---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                                         +COMP:N-N(of+        |                               |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +------OBJ:V-N------+COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 28

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+                               +---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                                         +COMP:N-N(of+        |                               |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +------OBJ:V-N------+COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 29

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+                               +---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                                         +COMP:N-N(of+        |                               |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +------OBJ:V-N------+COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 30

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+                               +---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                                         +COMP:N-N(of+        |                               |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +------OBJ:V-N------+COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 31

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+                               +---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                                         +COMP:N-N(of+        |                               |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +------OBJ:V-N------+COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 32

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+                               +---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                                         +COMP:N-N(of+        |                               |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +------OBJ:V-N------+COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 33

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+                               +---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                                         +COMP:N-N(of+        |                               |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +------OBJ:V-N------+COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 34

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+                               +---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                                         +COMP:N-N(of+        |                               |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +------OBJ:V-N------+COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 35

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+                               +---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                                         +COMP:N-N(of+        |                               |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +------OBJ:V-N------+COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 36

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+                               +---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                                         +COMP:N-N(of+        |                               |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +------OBJ:V-N------+COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 37

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+                   +---------------COMP:N-N(of)--------------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                                         +COMP:N-N(of+        |                   |                       +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +------OBJ:V-N------+COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 38

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+                   +---------------COMP:N-N(of)--------------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                                         +COMP:N-N(of+        |                   |                       +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +------OBJ:V-N------+COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 39

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+                   +---------------COMP:N-N(of)--------------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                                         +COMP:N-N(of+        |                   |                       +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +------OBJ:V-N------+COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 40

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+                   +---------------COMP:N-N(of)--------------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                                         +COMP:N-N(of+        |                   |                       +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +------OBJ:V-N------+COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 41

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+                   +---------------COMP:N-N(of)--------------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                                         +COMP:N-N(of+        |                   |                       +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +------OBJ:V-N------+COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 42

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+                   +---------------COMP:N-N(of)--------------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                                         +COMP:N-N(of+        |                   |                       +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +------OBJ:V-N------+COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 43

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+                   +---------------COMP:N-N(of)--------------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                                         +COMP:N-N(of+        |                   |                       +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +------OBJ:V-N------+COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 44

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+                               +---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                                         +COMP:N-N(of+        |                               |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +------OBJ:V-N------+COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 45

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+                               +---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                                         +COMP:N-N(of+        |                               |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +------OBJ:V-N------+COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 46

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+                               +---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                                         +COMP:N-N(of+        |                               |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +------OBJ:V-N------+COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 47

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+                   +---------------COMP:N-N(of)--------------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                                         +COMP:N-N(of+        |                   |                       +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +------OBJ:V-N------+COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 48

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+                   +---------------COMP:N-N(of)--------------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                                         +COMP:N-N(of+        |                   |                       +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +------OBJ:V-N------+COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 49

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+                   +---------------COMP:N-N(of)--------------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                                         +COMP:N-N(of+        |                   |                       +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +------OBJ:V-N------+COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 50

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+                               +---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                                         +COMP:N-N(of+        |                               |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +------OBJ:V-N------+COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 51

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+                               +---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                                         +COMP:N-N(of+        |                               |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +------OBJ:V-N------+COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 52

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+                               +---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                                         +COMP:N-N(of+        |                               |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +------OBJ:V-N------+COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 53

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+                   +---------------COMP:N-N(of)--------------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                                         +COMP:N-N(of+        |                   |                       +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +------OBJ:V-N------+COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 54

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+                   +---------------COMP:N-N(of)--------------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                                         +COMP:N-N(of+        |                   |                       +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +------OBJ:V-N------+COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 55

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+                   +---------------COMP:N-N(of)--------------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                                         +COMP:N-N(of+        |                   |                       +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +------OBJ:V-N------+COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 56

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+                   +---------------COMP:N-N(of)--------------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                                         +COMP:N-N(of+        |                   |                       +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +------OBJ:V-N------+COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 57

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+                   +---------------COMP:N-N(of)--------------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                                         +COMP:N-N(of+        |                   |                       +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +------OBJ:V-N------+COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 58

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+                   +---------------COMP:N-N(of)--------------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                                         +COMP:N-N(of+        |                   |                       +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +------OBJ:V-N------+COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 59

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+                   +---------------COMP:N-N(of)--------------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                                         +COMP:N-N(of+        |                   |                       +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +------OBJ:V-N------+COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 60

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+      +------COMP:N-N(in)------+---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                                         +COMP:N-N(of+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (little,expression)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 61

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+      +------COMP:N-N(in)------+---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                                         +COMP:N-N(of+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (little,expression)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 62

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+      +------COMP:N-N(in)------+---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                                         +COMP:N-N(of+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (little,expression)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 63

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+      +------COMP:N-N(in)------+---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                                         +COMP:N-N(of+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (little,expression)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 64

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+      +------COMP:N-N(in)------+---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                                         +COMP:N-N(of+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (little,expression)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 65

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+      +------COMP:N-N(in)------+---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                                         +COMP:N-N(of+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (little,expression)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 66

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+      +------COMP:N-N(in)------+---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                                         +COMP:N-N(of+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (little,expression)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 67

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+      +------COMP:N-N(in)------+---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                                         +COMP:N-N(of+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (little,expression)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 68

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+      +------COMP:N-N(in)------+---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                                         +COMP:N-N(of+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (little,expression)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 69

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+      +------COMP:N-N(in)------+---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                                         +COMP:N-N(of+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (little,expression)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 70

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+      +------COMP:N-N(in)------+---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                                         +COMP:N-N(of+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (little,expression)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 71

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+      +------COMP:N-N(in)------+---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                                         +COMP:N-N(of+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (little,expression)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 72

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+      +------COMP:N-N(in)------+---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                                         +COMP:N-N(of+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (little,expression)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 73

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+      +------COMP:N-N(in)------+---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                                         +COMP:N-N(of+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (little,expression)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 74

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+      +------COMP:N-N(in)------+---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                                         +COMP:N-N(of+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (little,expression)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 75

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+      +---------------------COMP:N-N(of)---------------------+      
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+      |            +---------------COMP:N-N(of)--------------+      
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+      +------COMP:N-N(in)------+                             |      
         +--MOD_ATT:N-ADJ--+                  |                 |                                         +COMP:N-N(of+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (little,expression)
COMP:N-N(of) (little,protein(s))
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 76

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+      +---------------------COMP:N-N(of)---------------------+      
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+      |            +---------------COMP:N-N(of)--------------+      
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+      +------COMP:N-N(in)------+                             |      
         +--MOD_ATT:N-ADJ--+                  |                 |                                         +COMP:N-N(of+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (little,expression)
COMP:N-N(of) (little,protein(s))
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 77

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+      +---------------------COMP:N-N(of)---------------------+      
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+      |            +---------------COMP:N-N(of)--------------+      
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+      +------COMP:N-N(in)------+                             |      
         +--MOD_ATT:N-ADJ--+                  |                 |                                         +COMP:N-N(of+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (little,expression)
COMP:N-N(of) (little,protein(s))
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 78

                                                                                                                                      +---------------------COMP:N-N(of)---------------------+      
                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+      |            +---------------COMP:N-N(of)--------------+      
                           |                                    +---------------------------SUBJ:V-N---------------------------+      +------COMP:N-N(in)------+                             |      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                                         +COMP:N-N(of+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (little,expression)
COMP:N-N(of) (little,protein(s))
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 79

                                                                                                                                      +---------------------COMP:N-N(of)---------------------+      
                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+      |            +---------------COMP:N-N(of)--------------+      
                           |                                    +---------------------------SUBJ:V-N---------------------------+      +------COMP:N-N(in)------+                             |      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                                         +COMP:N-N(of+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (little,expression)
COMP:N-N(of) (little,protein(s))
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 80

                                                                                                                                      +---------------------COMP:N-N(of)---------------------+      
                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+      |            +---------------COMP:N-N(of)--------------+      
                           |                                    +---------------------------SUBJ:V-N---------------------------+      +------COMP:N-N(in)------+                             |      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                                         +COMP:N-N(of+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (little,expression)
COMP:N-N(of) (little,protein(s))
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 81

                                                                                                                                      +---------------------COMP:N-N(of)---------------------+      
                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+      |            +---------------COMP:N-N(of)--------------+      
                           |                                    +---------------------------SUBJ:V-N---------------------------+      +------COMP:N-N(in)------+                             |      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                                         +COMP:N-N(of+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (little,expression)
COMP:N-N(of) (little,protein(s))
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 82

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+      +---------------------COMP:N-N(of)---------------------+      
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+      |            +---------------COMP:N-N(of)--------------+      
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+      +------COMP:N-N(in)------+                             |      
         +--MOD_ATT:N-ADJ--+                  |                 |                                         +COMP:N-N(of+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (little,expression)
COMP:N-N(of) (little,protein(s))
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 83

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+      +---------------------COMP:N-N(of)---------------------+      
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+      |            +---------------COMP:N-N(of)--------------+      
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+      +------COMP:N-N(in)------+                             |      
         +--MOD_ATT:N-ADJ--+                  |                 |                                         +COMP:N-N(of+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (little,expression)
COMP:N-N(of) (little,protein(s))
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 84

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+      +---------------------COMP:N-N(of)---------------------+      
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+      |            +---------------COMP:N-N(of)--------------+      
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+      +------COMP:N-N(in)------+                             |      
         +--MOD_ATT:N-ADJ--+                  |                 |                                         +COMP:N-N(of+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (little,expression)
COMP:N-N(of) (little,protein(s))
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 85

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+      +---------------------COMP:N-N(of)---------------------+      
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+      |            +---------------COMP:N-N(of)--------------+      
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+      +------COMP:N-N(in)------+                             |      
         +--MOD_ATT:N-ADJ--+                  |                 |                                         +COMP:N-N(of+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (little,expression)
COMP:N-N(of) (little,protein(s))
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 86

                                                                                                                                      +---------------------COMP:N-N(of)---------------------+      
                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+      |            +---------------COMP:N-N(of)--------------+      
                           |                                    +---------------------------SUBJ:V-N---------------------------+      +------COMP:N-N(in)------+                             |      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                                         +COMP:N-N(of+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (little,expression)
COMP:N-N(of) (little,protein(s))
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 87

                                                                                                                                      +---------------------COMP:N-N(of)---------------------+      
                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+      |            +---------------COMP:N-N(of)--------------+      
                           |                                    +---------------------------SUBJ:V-N---------------------------+      +------COMP:N-N(in)------+                             |      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                                         +COMP:N-N(of+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (little,expression)
COMP:N-N(of) (little,protein(s))
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 88

                                                                                                                                      +---------------------COMP:N-N(of)---------------------+      
                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+      |            +---------------COMP:N-N(of)--------------+      
                           |                                    +---------------------------SUBJ:V-N---------------------------+      +------COMP:N-N(in)------+                             |      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                                         +COMP:N-N(of+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (little,expression)
COMP:N-N(of) (little,protein(s))
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 89

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+                               +---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                                         +COMP:N-N(of+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 90

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+                               +---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                                         +COMP:N-N(of+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 91

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+                               +---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                                         +COMP:N-N(of+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 92

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+                               +---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                                         +COMP:N-N(of+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 93

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+                               +---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                                         +COMP:N-N(of+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 94

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+                               +---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                                         +COMP:N-N(of+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 95

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+                               +---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                                         +COMP:N-N(of+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 96

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+                   +---------------COMP:N-N(of)--------------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                                         +COMP:N-N(of+        +------OBJ:V-N------+                       +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 97

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+                   +---------------COMP:N-N(of)--------------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                                         +COMP:N-N(of+        +------OBJ:V-N------+                       +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 98

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+                   +---------------COMP:N-N(of)--------------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                                         +COMP:N-N(of+        +------OBJ:V-N------+                       +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 99

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+                               +---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                                         +COMP:N-N(of+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 100

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+                               +---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                                         +COMP:N-N(of+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 101

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+                               +---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                                         +COMP:N-N(of+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 102

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+                               +---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                                         +COMP:N-N(of+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 103

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+                   +---------------COMP:N-N(of)--------------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                                         +COMP:N-N(of+        +------OBJ:V-N------+                       +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 104

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+                   +---------------COMP:N-N(of)--------------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                                         +COMP:N-N(of+        +------OBJ:V-N------+                       +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 105

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+                   +---------------COMP:N-N(of)--------------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                                         +COMP:N-N(of+        +------OBJ:V-N------+                       +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 106

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+                   +---------------COMP:N-N(of)--------------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                                         +COMP:N-N(of+        +------OBJ:V-N------+                       +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 107

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+                   +---------------COMP:N-N(of)--------------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                                         +COMP:N-N(of+        +------OBJ:V-N------+                       +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 108

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+                   +---------------COMP:N-N(of)--------------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                                         +COMP:N-N(of+        +------OBJ:V-N------+                       +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 109

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+                               +---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                                         +COMP:N-N(of+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 110

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+                               +---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                                         +COMP:N-N(of+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 111

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+                   +---------------COMP:N-N(of)--------------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                                         +COMP:N-N(of+        +------OBJ:V-N------+                       +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 112

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+                   +---------------COMP:N-N(of)--------------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                                         +COMP:N-N(of+        +------OBJ:V-N------+                       +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 113

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+                   +---------------COMP:N-N(of)--------------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                                         +COMP:N-N(of+        +------OBJ:V-N------+                       +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 114

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+                   +---------------COMP:N-N(of)--------------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                                         +COMP:N-N(of+        +------OBJ:V-N------+                       +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 115

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+                   +---------------COMP:N-N(of)--------------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                                         +COMP:N-N(of+        +------OBJ:V-N------+                       +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 116

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+                   +---------------COMP:N-N(of)--------------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                                         +COMP:N-N(of+        +------OBJ:V-N------+                       +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 117

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+                   +---------------COMP:N-N(of)--------------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                                         +COMP:N-N(of+        +------OBJ:V-N------+                       +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+       +MOD+        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |                 |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 118

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+                               +---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                       +-----------OBJ:V-N-----------+        +----------COMP:V-N(in)---------+           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +------OBJ:V-N------+           |           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:V-N(in) (cause,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 119

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+                               +---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                       +-----------OBJ:V-N-----------+        +----------COMP:V-N(in)---------+           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +------OBJ:V-N------+           |           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:V-N(in) (cause,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 120

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+                               +---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                       +-----------OBJ:V-N-----------+        +----------COMP:V-N(in)---------+           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +------OBJ:V-N------+           |           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:V-N(in) (cause,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 121

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+                               +---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                       +-----------OBJ:V-N-----------+        +----------COMP:V-N(in)---------+           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +------OBJ:V-N------+           |           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:V-N(in) (cause,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 122

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+                               +---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                       +-----------OBJ:V-N-----------+        +----------COMP:V-N(in)---------+           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +------OBJ:V-N------+           |           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:V-N(in) (cause,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 123

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+                               +---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                       +-----------OBJ:V-N-----------+        +----------COMP:V-N(in)---------+           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +------OBJ:V-N------+           |           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:V-N(in) (cause,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 124

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+                               +---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                       +-----------OBJ:V-N-----------+        +----------COMP:V-N(in)---------+           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +------OBJ:V-N------+           |           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:V-N(in) (cause,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 125

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+                               +---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                       +-----------OBJ:V-N-----------+        +----------COMP:V-N(in)---------+           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +------OBJ:V-N------+           |           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:V-N(in) (cause,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 126

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+                               +---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                       +-----------OBJ:V-N-----------+        +----------COMP:V-N(in)---------+           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +------OBJ:V-N------+           |           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:V-N(in) (cause,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 127

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+                               +---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                       +-----------OBJ:V-N-----------+        +----------COMP:V-N(in)---------+           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +------OBJ:V-N------+           |           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:V-N(in) (cause,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 128

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+                               +---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                       +-----------OBJ:V-N-----------+        +----------COMP:V-N(in)---------+           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +------OBJ:V-N------+           |           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:V-N(in) (cause,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 129

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+                               +---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                       +-----------OBJ:V-N-----------+        +----------COMP:V-N(in)---------+           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +------OBJ:V-N------+           |           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:V-N(in) (cause,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 130

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+                               +---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                       +-----------OBJ:V-N-----------+        +----------COMP:V-N(in)---------+           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +------OBJ:V-N------+           |           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:V-N(in) (cause,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 131

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+                               +---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                       +-----------OBJ:V-N-----------+        +----------COMP:V-N(in)---------+           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +------OBJ:V-N------+           |           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:V-N(in) (cause,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 132

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+                               +---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                       +-----------OBJ:V-N-----------+        +----------COMP:V-N(in)---------+           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +------OBJ:V-N------+           |           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:V-N(in) (cause,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 133

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+----------COMP:V-N(in)---------+---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                       +-----------OBJ:V-N-----------+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +OBJ:V-+            |           |           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:V-N(in) (cause,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 134

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+----------COMP:V-N(in)---------+---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                       +-----------OBJ:V-N-----------+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +OBJ:V-+            |           |           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:V-N(in) (cause,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 135

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+----------COMP:V-N(in)---------+---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                       +-----------OBJ:V-N-----------+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +OBJ:V-+            |           |           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:V-N(in) (cause,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 136

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+----------COMP:V-N(in)---------+---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                       +-----------OBJ:V-N-----------+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +OBJ:V-+            |           |           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:V-N(in) (cause,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 137

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+----------COMP:V-N(in)---------+---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                       +-----------OBJ:V-N-----------+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +OBJ:V-+            |           |           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:V-N(in) (cause,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 138

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+----------COMP:V-N(in)---------+---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                       +-----------OBJ:V-N-----------+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +OBJ:V-+            |           |           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:V-N(in) (cause,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 139

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+----------COMP:V-N(in)---------+---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                       +-----------OBJ:V-N-----------+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +OBJ:V-+            |           |           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:V-N(in) (cause,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 140

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+----------COMP:V-N(in)---------+---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                       +-----------OBJ:V-N-----------+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +OBJ:V-+            |           |           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:V-N(in) (cause,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 141

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+----------COMP:V-N(in)---------+---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                       +-----------OBJ:V-N-----------+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +OBJ:V-+            |           |           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:V-N(in) (cause,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 142

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+----------COMP:V-N(in)---------+---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                       +-----------OBJ:V-N-----------+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +OBJ:V-+            |           |           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:V-N(in) (cause,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 143

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+----------COMP:V-N(in)---------+---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                       +-----------OBJ:V-N-----------+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +OBJ:V-+            |           |           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:V-N(in) (cause,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 144

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+----------COMP:V-N(in)---------+---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                       +-----------OBJ:V-N-----------+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +OBJ:V-+            |           |           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:V-N(in) (cause,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 145

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+----------COMP:V-N(in)---------+---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                       +-----------OBJ:V-N-----------+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +OBJ:V-+            |           |           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:V-N(in) (cause,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 146

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+----------COMP:V-N(in)---------+---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                       +-----------OBJ:V-N-----------+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +OBJ:V-+            |           |           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:V-N(in) (cause,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 147

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+----------COMP:V-N(in)---------+---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                       +-----------OBJ:V-N-----------+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +OBJ:V-+            |           |           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:V-N(in) (cause,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 148

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+----------COMP:V-N(in)---------+---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                       +-----------OBJ:V-N-----------+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +OBJ:V-+            |           |           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:V-N(in) (cause,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 149

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+                               +---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                       +-----------OBJ:V-N-----------+        |                               |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +------OBJ:V-N------+COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 150

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+                               +---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                       +-----------OBJ:V-N-----------+        |                               |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +------OBJ:V-N------+COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 151

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+                               +---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                       +-----------OBJ:V-N-----------+        |                               |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +------OBJ:V-N------+COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 152

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+                               +---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                       +-----------OBJ:V-N-----------+        |                               |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +------OBJ:V-N------+COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 153

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+                               +---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                       +-----------OBJ:V-N-----------+        |                               |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +------OBJ:V-N------+COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 154

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+                               +---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                       +-----------OBJ:V-N-----------+        |                               |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +------OBJ:V-N------+COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 155

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+                               +---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                       +-----------OBJ:V-N-----------+        |                               |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +------OBJ:V-N------+COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 156

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+                   +---------------COMP:N-N(of)--------------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                       +-----------OBJ:V-N-----------+        |                   |                       +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +------OBJ:V-N------+COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 157

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+                   +---------------COMP:N-N(of)--------------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                       +-----------OBJ:V-N-----------+        |                   |                       +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +------OBJ:V-N------+COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 158

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+                   +---------------COMP:N-N(of)--------------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                       +-----------OBJ:V-N-----------+        |                   |                       +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +------OBJ:V-N------+COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 159

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+                   +---------------COMP:N-N(of)--------------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                       +-----------OBJ:V-N-----------+        |                   |                       +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +------OBJ:V-N------+COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 160

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+                               +---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                       +-----------OBJ:V-N-----------+        |                               |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +------OBJ:V-N------+COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 161

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+                               +---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                       +-----------OBJ:V-N-----------+        |                               |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +------OBJ:V-N------+COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 162

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+                               +---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                       +-----------OBJ:V-N-----------+        |                               |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +------OBJ:V-N------+COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 163

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+                   +---------------COMP:N-N(of)--------------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                       +-----------OBJ:V-N-----------+        |                   |                       +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +------OBJ:V-N------+COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 164

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+                   +---------------COMP:N-N(of)--------------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                       +-----------OBJ:V-N-----------+        |                   |                       +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +------OBJ:V-N------+COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 165

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+                               +---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                       +-----------OBJ:V-N-----------+        |                               |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +------OBJ:V-N------+COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 166

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+                               +---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                       +-----------OBJ:V-N-----------+        |                               |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +------OBJ:V-N------+COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 167

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+                   +---------------COMP:N-N(of)--------------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                       +-----------OBJ:V-N-----------+        |                   |                       +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +------OBJ:V-N------+COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 168

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+                   +---------------COMP:N-N(of)--------------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                       +-----------OBJ:V-N-----------+        |                   |                       +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +------OBJ:V-N------+COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 169

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+                   +---------------COMP:N-N(of)--------------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                       +-----------OBJ:V-N-----------+        |                   |                       +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +------OBJ:V-N------+COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 170

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+                   +---------------COMP:N-N(of)--------------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                       +-----------OBJ:V-N-----------+        |                   |                       +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +------OBJ:V-N------+COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 171

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+                   +---------------COMP:N-N(of)--------------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                       +-----------OBJ:V-N-----------+        |                   |                       +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +------OBJ:V-N------+COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 172

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+                   +---------------COMP:N-N(of)--------------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                       +-----------OBJ:V-N-----------+        |                   |                       +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +------OBJ:V-N------+COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 173

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+                   +---------------COMP:N-N(of)--------------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                       +-----------OBJ:V-N-----------+        |                   |                       +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +------OBJ:V-N------+COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 174

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+                   +---------------COMP:N-N(of)--------------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                       +-----------OBJ:V-N-----------+        |                   |                       +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +------OBJ:V-N------+COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |                   |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 175

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+      +------COMP:N-N(in)------+---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                       +-----------OBJ:V-N-----------+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (little,expression)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 176

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+      +------COMP:N-N(in)------+---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                       +-----------OBJ:V-N-----------+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (little,expression)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 177

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+      +------COMP:N-N(in)------+---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                       +-----------OBJ:V-N-----------+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (little,expression)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 178

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+      +------COMP:N-N(in)------+---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                       +-----------OBJ:V-N-----------+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (little,expression)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 179

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+      +------COMP:N-N(in)------+---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                       +-----------OBJ:V-N-----------+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (little,expression)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 180

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+      +------COMP:N-N(in)------+---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                       +-----------OBJ:V-N-----------+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (little,expression)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 181

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+      +------COMP:N-N(in)------+---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                       +-----------OBJ:V-N-----------+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (little,expression)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 182

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+      +------COMP:N-N(in)------+---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                       +-----------OBJ:V-N-----------+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (little,expression)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 183

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+      +------COMP:N-N(in)------+---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                       +-----------OBJ:V-N-----------+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (little,expression)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 184

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+      +------COMP:N-N(in)------+---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                       +-----------OBJ:V-N-----------+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (little,expression)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 185

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+      +------COMP:N-N(in)------+---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                       +-----------OBJ:V-N-----------+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (little,expression)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 186

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+      +------COMP:N-N(in)------+---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                       +-----------OBJ:V-N-----------+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (little,expression)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 187

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+      +------COMP:N-N(in)------+---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                       +-----------OBJ:V-N-----------+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (little,expression)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 188

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+      +------COMP:N-N(in)------+---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                       +-----------OBJ:V-N-----------+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (little,expression)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 189

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+      +------COMP:N-N(in)------+---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                       +-----------OBJ:V-N-----------+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (little,expression)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 190

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+      +---------------------COMP:N-N(of)---------------------+      
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+      |            +---------------COMP:N-N(of)--------------+      
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+      +------COMP:N-N(in)------+                             |      
         +--MOD_ATT:N-ADJ--+                  |                 |                       +-----------OBJ:V-N-----------+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (little,expression)
COMP:N-N(of) (little,protein(s))
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 191

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+      +---------------------COMP:N-N(of)---------------------+      
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+      |            +---------------COMP:N-N(of)--------------+      
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+      +------COMP:N-N(in)------+                             |      
         +--MOD_ATT:N-ADJ--+                  |                 |                       +-----------OBJ:V-N-----------+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (little,expression)
COMP:N-N(of) (little,protein(s))
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 192

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+      +---------------------COMP:N-N(of)---------------------+      
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+      |            +---------------COMP:N-N(of)--------------+      
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+      +------COMP:N-N(in)------+                             |      
         +--MOD_ATT:N-ADJ--+                  |                 |                       +-----------OBJ:V-N-----------+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (little,expression)
COMP:N-N(of) (little,protein(s))
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 193

                                                                                                                                      +---------------------COMP:N-N(of)---------------------+      
                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+      |            +---------------COMP:N-N(of)--------------+      
                           |                                    +---------------------------SUBJ:V-N---------------------------+      +------COMP:N-N(in)------+                             |      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                       +-----------OBJ:V-N-----------+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (little,expression)
COMP:N-N(of) (little,protein(s))
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 194

                                                                                                                                      +---------------------COMP:N-N(of)---------------------+      
                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+      |            +---------------COMP:N-N(of)--------------+      
                           |                                    +---------------------------SUBJ:V-N---------------------------+      +------COMP:N-N(in)------+                             |      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                       +-----------OBJ:V-N-----------+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (little,expression)
COMP:N-N(of) (little,protein(s))
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 195

                                                                                                                                      +---------------------COMP:N-N(of)---------------------+      
                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+      |            +---------------COMP:N-N(of)--------------+      
                           |                                    +---------------------------SUBJ:V-N---------------------------+      +------COMP:N-N(in)------+                             |      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                       +-----------OBJ:V-N-----------+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (little,expression)
COMP:N-N(of) (little,protein(s))
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 196

                                                                                                                                      +---------------------COMP:N-N(of)---------------------+      
                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+      |            +---------------COMP:N-N(of)--------------+      
                           |                                    +---------------------------SUBJ:V-N---------------------------+      +------COMP:N-N(in)------+                             |      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                       +-----------OBJ:V-N-----------+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (little,expression)
COMP:N-N(of) (little,protein(s))
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 197

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+      +---------------------COMP:N-N(of)---------------------+      
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+      |            +---------------COMP:N-N(of)--------------+      
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+      +------COMP:N-N(in)------+                             |      
         +--MOD_ATT:N-ADJ--+                  |                 |                       +-----------OBJ:V-N-----------+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (little,expression)
COMP:N-N(of) (little,protein(s))
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 198

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+      +---------------------COMP:N-N(of)---------------------+      
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+      |            +---------------COMP:N-N(of)--------------+      
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+      +------COMP:N-N(in)------+                             |      
         +--MOD_ATT:N-ADJ--+                  |                 |                       +-----------OBJ:V-N-----------+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (little,expression)
COMP:N-N(of) (little,protein(s))
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 199

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+      +---------------------COMP:N-N(of)---------------------+      
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+      |            +---------------COMP:N-N(of)--------------+      
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+      +------COMP:N-N(in)------+                             |      
         +--MOD_ATT:N-ADJ--+                  |                 |                       +-----------OBJ:V-N-----------+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (little,expression)
COMP:N-N(of) (little,protein(s))
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 200

                                                                                                                                      +---------------------COMP:N-N(of)---------------------+      
                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+      |            +---------------COMP:N-N(of)--------------+      
                           |                                    +---------------------------SUBJ:V-N---------------------------+      +------COMP:N-N(in)------+                             |      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                       +-----------OBJ:V-N-----------+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (little,expression)
COMP:N-N(of) (little,protein(s))
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 201

                                                                                                                                      +---------------------COMP:N-N(of)---------------------+      
                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+      |            +---------------COMP:N-N(of)--------------+      
                           |                                    +---------------------------SUBJ:V-N---------------------------+      +------COMP:N-N(in)------+                             |      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                       +-----------OBJ:V-N-----------+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (little,expression)
COMP:N-N(of) (little,protein(s))
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 202

                                                                                                                                      +---------------------COMP:N-N(of)---------------------+      
                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+      |            +---------------COMP:N-N(of)--------------+      
                           |                                    +---------------------------SUBJ:V-N---------------------------+      +------COMP:N-N(in)------+                             |      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                       +-----------OBJ:V-N-----------+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (little,expression)
COMP:N-N(of) (little,protein(s))
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 203

                                                                                                                                      +---------------------COMP:N-N(of)---------------------+      
                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+      |            +---------------COMP:N-N(of)--------------+      
                           |                                    +---------------------------SUBJ:V-N---------------------------+      +------COMP:N-N(in)------+                             |      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                       +-----------OBJ:V-N-----------+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (little,expression)
COMP:N-N(of) (little,protein(s))
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 204

                                                                                                                                      +---------------------COMP:N-N(of)---------------------+      
                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+      |            +---------------COMP:N-N(of)--------------+      
                           |                                    +---------------------------SUBJ:V-N---------------------------+      +------COMP:N-N(in)------+                             |      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                       +-----------OBJ:V-N-----------+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (little,expression)
COMP:N-N(of) (little,protein(s))
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 205

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+                               +---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                       +-----------OBJ:V-N-----------+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 206

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+                               +---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                       +-----------OBJ:V-N-----------+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 207

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+                               +---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                       +-----------OBJ:V-N-----------+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 208

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+                               +---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                       +-----------OBJ:V-N-----------+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 209

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+                               +---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                       +-----------OBJ:V-N-----------+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 210

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+                               +---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                       +-----------OBJ:V-N-----------+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 211

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+                               +---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                       +-----------OBJ:V-N-----------+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 212

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+                               +---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                       +-----------OBJ:V-N-----------+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 213

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+                               +---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                       +-----------OBJ:V-N-----------+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 214

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+                   +---------------COMP:N-N(of)--------------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                       +-----------OBJ:V-N-----------+        +------OBJ:V-N------+                       +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 215

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+                   +---------------COMP:N-N(of)--------------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                       +-----------OBJ:V-N-----------+        +------OBJ:V-N------+                       +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 216

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+                   +---------------COMP:N-N(of)--------------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                       +-----------OBJ:V-N-----------+        +------OBJ:V-N------+                       +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 217

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+                               +---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                       +-----------OBJ:V-N-----------+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 218

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+                               +---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                       +-----------OBJ:V-N-----------+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 219

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+                               +---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                       +-----------OBJ:V-N-----------+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 220

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+                               +---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                       +-----------OBJ:V-N-----------+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 221

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+                   +---------------COMP:N-N(of)--------------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                       +-----------OBJ:V-N-----------+        +------OBJ:V-N------+                       +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 222

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+                   +---------------COMP:N-N(of)--------------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                       +-----------OBJ:V-N-----------+        +------OBJ:V-N------+                       +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 223

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+                   +---------------COMP:N-N(of)--------------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                       +-----------OBJ:V-N-----------+        +------OBJ:V-N------+                       +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 224

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+                   +---------------COMP:N-N(of)--------------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                       +-----------OBJ:V-N-----------+        +------OBJ:V-N------+                       +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 225

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+                               +---------COMP:N-N(of)--------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                       +-----------OBJ:V-N-----------+        +------OBJ:V-N------+           |           +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 226

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+                   +---------------COMP:N-N(of)--------------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                       +-----------OBJ:V-N-----------+        +------OBJ:V-N------+                       +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 227

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+                   +---------------COMP:N-N(of)--------------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                       +-----------OBJ:V-N-----------+        +------OBJ:V-N------+                       +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 228

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+                   +---------------COMP:N-N(of)--------------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                       +-----------OBJ:V-N-----------+        +------OBJ:V-N------+                       +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 229

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                  +---------------------------------COMP:V-N(from)---------------------------------+                                                                    
                           |                  |                 +---------------------------SUBJ:V-N---------------------------+                   +---------------COMP:N-N(of)--------------+      
         +--MOD_ATT:N-ADJ--+                  |                 |                       +-----------OBJ:V-N-----------+        +------OBJ:V-N------+                       +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
COMP:V-N(from) (cause,__SP__)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 230

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+                   +---------------COMP:N-N(of)--------------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                       +-----------OBJ:V-N-----------+        +------OBJ:V-N------+                       +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 231

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+                   +---------------COMP:N-N(of)--------------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                       +-----------OBJ:V-N-----------+        +------OBJ:V-N------+                       +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 232

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+                   +---------------COMP:N-N(of)--------------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                       +-----------OBJ:V-N-----------+        +------OBJ:V-N------+                       +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)

Analyse 233

                           +--------------------------------------------COMP:V-N(In)-------------------------------------------+                                                                    
                           |                                    +---------------------------SUBJ:V-N---------------------------+                   +---------------COMP:N-N(of)--------------+      
         +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+                 |                       +-----------OBJ:V-N-----------+        +------OBJ:V-N------+                       +--MOD_ATT:N-ADJ--+      
         |        +MOD_ATT:+           +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N-+   |        +OBJ:V-+            +COMP:N-N(in+           |       +MOD_ATT:N+      
         |        |        |           |      |       |         |              |        |        |        |       |   |        |      |            |           |           |       |         |      
 In periportal region of liver from female __SP__ , oral administration of __NODE__ ( with a treatment period of 24 weeks ) causes little or no change in expression of __SP__ __NODE__ protein(s) .
MOD_ATT:N-ADJ (liver,periportal)
MOD_ATT:N-N (liver,region)
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (cause,liver)
SUBJ:V-N (cause,administration)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,protein(s))
MOD_ATT:N-ADJ (protein(s),__SP__)
MOD_ATT:N-ADJ (protein(s),__NODE__)